cncpt-artikel_lb_atf
Upadacitinib Benefits Ulcerative Colitis Patients – ECCO23 Data
At ECCO23, new data was presented that demonstrated sustained benefits of upadacitinib in achieving symptom resolution and fatigue normalization in patients with active ulcerative colitis.